Evidence map›Paper›PMID 35579673›Full record

ReviewHNO2023

[Diagnostics and treatment of secondary malignancies of the parotid gland-An overview].

Marcel Mayer, Lisa Nachtsheim, Christoph Arolt, Alexander Quaas, Johanna Prinz, Maria Grosheva, Jens Peter Klußmann, Philipp Wolber

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in HNO, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marcel MayerMedizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland. marcel.mayer@uk-koeln.de.ORCID http://orcid.org/0000-0001-9963-1109
Lisa NachtsheimMedizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Christoph AroltMedizinische Fakultät und Uniklinik Köln, Institut für Allgemeine Pathologie und Pathologische Anatomie, Universität zu Köln, Köln, Deutschland.
Alexander QuaasMedizinische Fakultät und Uniklinik Köln, Institut für Allgemeine Pathologie und Pathologische Anatomie, Universität zu Köln, Köln, Deutschland.
Johanna PrinzMedizinische Fakultät der Uniklinik Köln, Klinik für Innere Medizin I, Universität zu Köln, Köln, Deutschland.
Maria GroshevaMedizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Jens Peter KlußmannMedizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Philipp WolberMedizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie, Universität zu Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
University of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSecondary malignancies of the parotid gland frequently have a cutaneous origin and the incidence in central Europe is increasing.

objectiveThe aim of this review article was to present the epidemiology, (differential) diagnostics and treatment of secondary malignancies of the parotid gland. MATERIAL AND

methodsA literature search of the current guidelines and evidence was carried out in the web-based databank PubMed.

resultsThe incidence of secondary malignancies of the parotid gland seems to be increasing in Europe, mainly due to a rising incidence of metastases of cutaneous squamous cell carcinomas. Except for malignant lymphomas, parotidectomy is the treatment of choice in the curative situation. In the absence of clear evidence, in the case of an intact facial nerve lateral or total parotidectomy with ipsilateral neck dissection seems to be indicated, depending on the entity of the secondary malignancy.

conclusionThe differential diagnostics of squamous cell carcinoma (in) of the parotid gland can be complicated. When a squamous cell carcinoma of the parotid gland is diagnosed for the first time, a dermatological full body examination and a detailed medical history should be taken with respect to skin tumors of the head and neck region. In addition to surgical treatment of the parotid gland and neck, adjuvant radiotherapy is usually indicated.

Indexed as

Carcinoma, Squamous CellParotid NeoplasmsSkin NeoplasmsHumansNeck DissectionParotid GlandRetrospective StudiesCarcinoma, squamous cellFacial nerveNeck dissectionRadiotherapy, adjuvantSpinocellular carcinoma

Identifiers

PMID35579673
OpenAlexW4280494903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.